PRESS RELEASE published on 08/05/2023 at 02:12, 2 years 6 months ago BioNxt Solutions Announces Non-Brokered Private Placement
PRESS RELEASE published on 08/02/2023 at 09:00, 2 years 6 months ago BioNxt Signs LOI for Acquisition of IP and Co-Development of ODF Drug Reformulation for Neurodegenerative Disease
PRESS RELEASE published on 05/15/2023 at 09:05, 2 years 8 months ago BioNxt Receives Approval for European Clinical Study of Transdermal Rotigotine Patch for Parkinson’s Disease
PRESS RELEASE published on 05/09/2023 at 09:05, 2 years 8 months ago BioNxt Successfully Completes Pilot Study for Contract Development Customer
PRESS RELEASE published on 04/24/2023 at 09:05, 2 years 9 months ago BioNxt Secures Contract to Develop and Manufacture ODF Product for International Pharmaceutical Company
PRESS RELEASE published on 04/17/2023 at 09:05, 2 years 9 months ago BioNxt Acquires Commercial Coating and Cutting Equipment to Build Out European Commercial Manufacturing Capacity
PRESS RELEASE published on 04/15/2023 at 03:11, 2 years 9 months ago BioNxt Reports on Enteric Coating Drug Delivery Program
PRESS RELEASE published on 04/04/2023 at 04:50, 2 years 10 months ago BioNxt Solutions Announces Closing of Non-Brokered Private Placement and Grant of Stock Options
PRESS RELEASE published on 03/28/2023 at 05:25, 2 years 10 months ago BioNxt Solutions Closes First Tranche of Financing
PRESS RELEASE published on 03/10/2023 at 19:50, 2 years 10 months ago Bionxt Solutions Announces Non-Brokered Private Placement
Published on 02/05/2026 at 12:00, 21 minutes ago Datavault AI Chief Executive Officer and President Issues Letter to Stockholders Highlighting 2025 Accomplishments and Outlook for 2026
Published on 02/05/2026 at 09:05, 3 hours 16 minutes ago BioNxt Secures Innovative Chaperone Technology to Enhance Oral Thin-Film Drug Delivery
Published on 02/05/2026 at 01:35, 10 hours 46 minutes ago Dr. Ruben Shiffman Files Early Warning Report in Respect of Greenland Resources
Published on 02/05/2026 at 00:00, 12 hours 21 minutes ago Onco-Innovations Announces Filing of Preliminary Base Shelf Prospectus
Published on 02/04/2026 at 22:25, 13 hours 56 minutes ago 55 North Mining Announces Flow-Through Financing
Published on 02/05/2026 at 11:47, 34 minutes ago Worthington Steel Announces Start of Acceptance Period for All-Cash Tender Offer of €11.00 per Share to Shareholders of Kloeckner & Co SE
Published on 02/05/2026 at 11:45, 36 minutes ago EQS-WpÜG: Takeover Offer / Target company: Klöckner & Co SE; Bidder: Worthington Steel GmbH
Published on 02/05/2026 at 11:30, 51 minutes ago Linde Reports Full-Year and Fourth-Quarter 2025 Results (Earnings Release Tables Attached)
Published on 02/05/2026 at 11:30, 51 minutes ago Déclaration nombre d'actions et droits de vote - 05.02.2026
Published on 02/05/2026 at 11:30, 51 minutes ago Disclosure of shares outstanding and voting rights - 05.02.2026
Published on 02/04/2026 at 18:04, 18 hours 17 minutes ago Capital et droits de vote au 31 janvier 2026
Published on 02/04/2026 at 18:04, 18 hours 17 minutes ago Total number of voting rights and shares making up the share capital at January 31, 2026
Published on 02/04/2026 at 17:45, 18 hours 36 minutes ago Information concerning the total number of voting rights and shares 2026 01 31
